General Western Blot Reagents
Abcam x TT sodium salt, Tetrazolium salt, 50MG
MW 673.53 g/mol. Tetrazolium sodium salt for use in colorimetric assays for cell viability and proliferation. Cleavage of XTT by dehydrogenase enzymes of metabolically active cells yields a highly colored, water soluble formazan product, an advantage over the use of MTT due to MTT requiring a formazan crystal solubilization step. Has been used to asses valvular injury for testing cryopreserved cardiac valves.
The product is subject to the following: Abcam Restricted Use Statement
Abcam BMS 345541, IKK-2 and IKK-1 inhibitor, 10MG
MW 255.32 Da, Purity >98%. Highly selective cell permeable IKK-2 and IKK-1 inhibitor (IC₅₀ values are 0.3 and 4 μM for IKK-2 and IKK-1 respectively). Blocks NF-κB-dependent transcription. Shows anti-inflammatory and radiosensitizing effects in vivo. Orally active.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Circulating DNA Quantification Kit
Circulating DNA Quantification Kit
The product is subject to the following: Abcam Restricted Use Statement
Abcam Acetylcysteine (N-Acetyl-L-cysteine), ROS inhibitor, 50MG
MW 163.2 Da, Purity >99%. ROS inhibitor. L-cysteine prodrug. Mucolytic agent. Inhibits viral stimulation by reactive oxygen intermediates. Shows mucolytic, hepatoprotective and antiviral effects in vivo. Orally active.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Anhydrotetracycline hydrochloride, Tetracycline repressor, 500MG
MW 462.9 Da, Purity >98%. Tetracycline repressor and reverse tetracycline repressor effector. Tetracycline (ab141223, ab146579) derivative. Tetracycline-dependent gene expression effector in bacterial expression systems. Binds poorly to the 30S ribosomal subunit. Exhibits no antibiotic activity.
The product is subject to the following: Abcam Restricted Use Statement
Abcam N-Methyl-4-phenylpyridinium Iodide (MPP+), Dopaminergic selective neuroto x in, 50MG
MW 297.13 Da, Purity >98%. Dopaminergic selective neurotoxin. Active MPTP metabolite. Interferes with oxidative phosphorylation and induces mitochondrial dysfunction. Deplete cellular ATP. Shows Parkinson effects in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam Glucose Uptake Assay Kit (Fluorometric)
Glucose Uptake Assay Kit (Fluorometric)
The product is subject to the following: Abcam Restricted Use Statement
Abcam E3 Ligase Auto Ubiquitylation Assay Kit
E3 Ligase Auto Ubiquitylation Assay Kit
The product is subject to the following: Abcam Restricted Use Statement
Abcam Triacsin C, acyl-CoA synthetase inhibitor, 1MG
MW 207.27 Da, Purity >90%. Potent, specific acyl-CoA synthetase inhibitor (Ki values are 15 nM and 2 μM for Faa2p and Faa4p respectively). Inhibits synthesis of cholesteryl ester and triacylglycerol in vitro. Vasodilator agent. Orally active. Active in vivo and in vitro.
The product is subject to the following: Abcam Restricted Use Statement
Abcam ECL Substrate Kit (High Sensitivity), 20ML
High Sensitivity ECL Substrate Kit ab133406 is designed for the detection of proteins with 23pg-187ng of protein per band.
The product is subject to the following: Abcam Restricted Use Statement
Abcam MRS 2179, P2Y1 antagonist, 5MG
MW 460.27 Da, Purity >98%. Potent, selective, competitive P2Y1 antagonist (Ki = 100 nM). Inhibits ATP induced glutamate release *in vitro* and inhibits ADP ability to evoke platelet shape change and aggregation.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Bafilomycin A1, (V)-ATPase inhibitor, 10UG
MW 622.8 Da. Highly potent, selective vacuolar (V)-ATPase inhibitor (IC₅₀ = 500 pM in chromaffin granule membranes). Induces vacuolar deacidification and promotes apoptosis.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Citrate Synthase Activity Assay Kit
Citrate Synthase Activity Assay Kit
The product is subject to the following: Abcam Restricted Use Statement
Abcam MRS 2179, P2Y1 antagonist, 10MG
MW 460.27 Da, Purity >98%. Potent, selective, competitive P2Y1 antagonist (Ki = 100 nM). Inhibits ATP induced glutamate release *in vitro* and inhibits ADP ability to evoke platelet shape change and aggregation.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Z-VAD(OMe)-FMK, Cell permeable, irreversible pan-caspase inhibitor, 1MG
MW 467.5 Da, Purity >90%. Z-VAD(OMe)-FMK, Cell permeable, irreversible pan-caspase inhibitor. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement